SESEN BIO, INC.

EDGAR

Market value is not computed: no recent price is available.

Annual consolidated revenue for 2024: about USD 19.6M, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2023, was about USD 14.9M.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

5% holders (Schedule 13D and 13G)

  • HealthCap VII, L.P. 0.0% SCHEDULE 13D/A 09/02/2025
  • HealthCap VII GP LLC 0.0% SCHEDULE 13D/A 09/02/2025
  • HealthCap VII, L.P. 4.8% SCHEDULE 13D/A 08/27/2025

Institutional holders (Form 13F)

  • Ascentis Independent Advisors 4,200 SH
  • Union Bancaire Privee, UBP SA 785 SH

Trades by members of Congress

See all insider transactions

Latest quarter

Revenue

45.3 million USD

2025 Q3 · USD

Exact inputs and evidence

Operating margin

96.72%

2025 Q3 · %

Exact inputs and evidence
  • Operating Income: 43814000 USD Source
  • Revenue: 45300000 USD Source

Operating cash flow

1.91 million USD

2025 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -14063000 USD Source
  • Operating Cash Flow: -15971000 USD Source

Free cash flow

1.91 million USD

2025 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -14063000 USD Source
  • Operating Cash Flow: -15971000 USD Source
  • Capital Expenditure: 0 USD Source
  • Capital Expenditure: 0 USD Source
Cash and cash equivalents
2.78 million USD Source
Exact value

2777000 USD

Long-term debt including current maturities
Not available
Shares outstanding
41.8 million shares Source
Exact value

41788096 shares

Reported share-count change

0.09% · 38 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 41750109 shares · 2024-09-30· Source
  • 41788096 shares · 2025-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

52.6 million USD

2024-10-01 – 2025-09-30

Exact inputs and evidence
  • Revenue: 19600000 USD · 2024-01-01 – 2024-12-31 Source
  • Revenue: 16000000 USD · 2024-01-01 – 2024-09-30 Source
  • Revenue: 3700000 USD · 2025-01-01 – 2025-03-31 Source
  • Revenue: 3700000 USD · 2025-01-01 – 2025-06-30 Source
  • Revenue: 3700000 USD · 2025-01-01 – 2025-03-31 Source
  • Revenue: 45300000 USD · 2025-07-01 – 2025-09-30 Source

Net income

8.04 million USD

2024-10-01 – 2025-09-30

Exact inputs and evidence
  • Net income: -60477000 USD · 2024-01-01 – 2024-12-31 Source
  • Net income: -42842000 USD · 2024-01-01 – 2024-09-30 Source
  • Net income: -9266000 USD · 2025-01-01 – 2025-03-31 Source
  • Net income: -9774000 USD · 2025-04-01 – 2025-06-30 Source
  • Net income: 44717000 USD · 2025-07-01 – 2025-09-30 Source

Operating cash flow

-22.4 million USD

2024-10-01 – 2025-09-30

Exact inputs and evidence
  • Operating cash flow: -59917000 USD · 2024-01-01 – 2024-12-31 Source
  • Operating cash flow: -51565000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -10067000 USD · 2025-01-01 – 2025-03-31 Source
  • Operating cash flow: -15971000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -10067000 USD · 2025-01-01 – 2025-03-31 Source
  • Operating cash flow: -14063000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -15971000 USD · 2025-01-01 – 2025-06-30 Source

Capital expenditure

0 USD

2024-10-01 – 2025-09-30

Exact inputs and evidence
  • Capital expenditure: 123000 USD · 2024-01-01 – 2024-12-31 Source
  • Capital expenditure: 123000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 0 USD · 2025-01-01 – 2025-03-31 Source
  • Capital expenditure: 0 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 0 USD · 2025-01-01 – 2025-03-31 Source
  • Capital expenditure: 0 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 0 USD · 2025-01-01 – 2025-06-30 Source

Free cash flow

-22.4 million USD

2024-10-01 – 2025-09-30

Exact inputs and evidence
  • Operating cash flow: -59917000 USD · 2024-01-01 – 2024-12-31 Source
  • Operating cash flow: -51565000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -10067000 USD · 2025-01-01 – 2025-03-31 Source
  • Operating cash flow: -15971000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: -10067000 USD · 2025-01-01 – 2025-03-31 Source
  • Operating cash flow: -14063000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -15971000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 123000 USD · 2024-01-01 – 2024-12-31 Source
  • Capital expenditure: 123000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 0 USD · 2025-01-01 – 2025-03-31 Source
  • Capital expenditure: 0 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 0 USD · 2025-01-01 – 2025-03-31 Source
  • Capital expenditure: 0 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 0 USD · 2025-01-01 – 2025-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2025-11-12.

Financial data available through: 2024-12-31.

Coverage by financial measure
  • Revenue: 7 of 11 periods available· newest 2024-12-31
  • Operating income: 11 of 11 periods available· newest 2024-12-31
  • Net income: 11 of 11 periods available· newest 2024-12-31
  • Operating cash flow: 11 of 11 periods available· newest 2024-12-31
  • Capital expenditure: 10 of 11 periods available· newest 2024-12-31
  • Total assets: 7 of 11 periods available· newest 2024-12-31
  • Total liabilities: 3 of 11 periods available· newest 2024-12-31
  • Current assets: 7 of 11 periods available· newest 2024-12-31
  • Current liabilities: 7 of 11 periods available· newest 2024-12-31
  • Cash and cash equivalents: 7 of 11 periods available· newest 2024-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 7 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +31.5%

    Prior period

    USD 14.9 million

    –

    Current period

    USD 19.6 million

    –

    Exact inputs and evidence

    19600000 − 14900000 = 4700000 USD

    14900000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    19600000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 26.4 million

    Prior period

    −USD 86.88 million

    –

    Current period

    −USD 60.48 million

    –

    Exact inputs and evidence

    -60477000 − -86879000 = 26402000 USD

    -86879000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -60477000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 21.26 million

    Prior period

    −USD 81.18 million

    –

    Current period

    −USD 59.92 million

    –

    Exact inputs and evidence

    -59917000 − -81177000 = 21260000 USD

    -81177000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -59917000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -89.1%

    Prior period

    USD 1.13 million

    –

    Current period

    USD 123,000

    –

    Exact inputs and evidence

    123000 − 1132000 = -1009000 USD

    1132000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    123000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

  • Revenue USD 19.6 million 100% of revenue
  • Operating costs Derived USD 81.78 million 417% of revenue
  • Operating income −USD 62.18 million −317% of revenue
  • Tax, interest and other Derived −USD 1.7 million −8.7% of revenue
  • Net income −USD 60.48 million −309% of revenue

Cash

  • Operating cash flow −USD 59.92 million −306% of revenue
  • Capital expenditure USD 123,000 0.6% of revenue
  • Free cash flow Derived −USD 60.04 million −306% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2015 Operating loss: operating costs were 3,655% of revenue.
  • 2016 90%
  • 2017 Operating loss: operating costs were 6,984% of revenue.
  • 2022 Operating loss: operating costs were 673% of revenue.
  • 2023 Operating loss: operating costs were 696% of revenue.
  • 2024 Operating loss: operating costs were 417% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2015 2015-01-01 – 2015-12-31990000 36186000 Derived -35196000 -1744000 Derived -33452000 -34816000 Derived
Source
2016 2016-01-01 – 2016-12-3129981000 27115000 Derived 2866000 975000 Derived 1891000 Unavailable
Source
2017 2017-01-01 – 2017-12-31425000 29680000 Derived -29255000 -226000 Derived -29029000 -17810000 Derived
Source
2022 2022-01-01 – 2022-12-319800000 65962000 Derived -56162000 5064000 Derived -61226000 -9776000 Derived
Source
2023 2023-01-01 – 2023-12-3114900000 103631000 Derived -88731000 -1852000 Derived -86879000 -82309000 Derived
Source
2024 2024-01-01 – 2024-12-3119600000 81779000 Derived -62179000 -1702000 Derived -60477000 -60040000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 19.6M 2024
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.32.4M24.3M16.2M8.1M0.0201420172024
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2014Revenue2243000
2015Revenue990000
2016Revenue29981000
2017Revenue425000
2022Revenue9800000
2023Revenue14900000
2024Revenue19600000

Revenue growth

Change in revenue from the same financial period one year earlier.

31.5% 2024
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3,171%2,293%1,415%537%-341%201420172024
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2014Year over yearNo prior comparable period
2015Year over year-55.9%
2016Year over year2,928.4%
2017Year over year-98.6%
2022Year over yearNo prior comparable period
2023Year over year52%
2024Year over year31.5%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -317.2% 2024
Net margin -308.6% 2024
Free cash flow margin -306.3% 2024
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.561%-1,438%-3,437%-5,436%-7,435%201420172024
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2014Operating margin-1,468.2%
2015Operating margin-3,555.2%
2016Operating margin9.6%
2017Operating margin-6,883.5%
2022Operating margin-573.1%
2023Operating margin-595.5%
2024Operating margin-317.2%
2014Net margin-1,522.8%
2015Net margin-3,379%
2016Net margin6.3%
2017Net margin-6,830.4%
2022Net margin-624.8%
2023Net margin-583.1%
2024Net margin-308.6%
2014Free cash flow marginNot reported
2015Free cash flow margin-3,516.8%
2016Free cash flow marginNot reported
2017Free cash flow margin-4,190.6%
2022Free cash flow margin-99.8%
2023Free cash flow margin-552.4%
2024Free cash flow margin-306.3%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -59.9M 2024
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.9.2M-15.0M-39.3M-63.6M-87.9M201420172024
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2014Operating cash flowNot reportedNo source recorded
2015Operating cash flow-34529000
2016Operating cash flow2538000
2017Operating cash flow-17800000
2022Operating cash flow-5116000
2023Operating cash flow-81177000
2024Operating cash flow-59917000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -60M 2024
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6.6M-17.3M-41.2M-65.0M-88.9M201420172024
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2014Free cash flowUnavailableNo source recorded
2015Free cash flow-34816000
2016Free cash flowUnavailable
2017Free cash flow-17810000
2022Free cash flow-9776000
2023Free cash flow-82309000
2024Free cash flow-60040000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

191.6% 2024
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.207%155%103%52%0%2014-12-312017-12-312024
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2014-12-31Liabilities / assetsNot reported
2015-12-31Liabilities / assetsNot reported
2016-12-31Liabilities / assetsNot reported
2017-12-31Liabilities / assetsNot reported
2022Liabilities / assets148.3%
2023Liabilities / assets70.4%
2024Liabilities / assets191.6%

Current assets to current liabilities

Current assets divided by current liabilities.

1.48× 2024
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.11.29×8.47×5.65×2.82×0.00×201420172024
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2014Current assets / current liabilities10.46×
2015Current assets / current liabilities4.79×
2016Current assets / current liabilities6.51×
2017Current assets / current liabilities3.17×
2022Current assets / current liabilities2.78×
2023Current assets / current liabilities5.06×
2024Current assets / current liabilities1.48×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2015 2015-01-01 – 2015-12-31
−USD 33.45 million
Exact value

Exact value: -33452000 USD

2015-01-01 – 2015-12-31: -33452000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 34.53 million
Exact value

Exact value: -34529000 USD

2015-01-01 – 2015-12-31: -34529000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 287,000
Exact value

Exact value: 287000 USD

2015-01-01 – 2015-12-31: 287000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 34.82 million
Calculation and evidence

-34529000 − 287000 USD

Exact free cash flow: -34816000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2016 2016-01-01 – 2016-12-31
USD 1.89 million
Exact value

Exact value: 1891000 USD

2016-01-01 – 2016-12-31: 1891000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.54 million
Exact value

Exact value: 2538000 USD

2016-01-01 – 2016-12-31: 2538000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2017 2017-01-01 – 2017-12-31
−USD 29.03 million
Exact value

Exact value: -29029000 USD

2017-01-01 – 2017-12-31: -29029000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 17.8 million
Exact value

Exact value: -17800000 USD

2017-01-01 – 2017-12-31: -17800000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 10,000
Exact value

Exact value: 10000 USD

2017-01-01 – 2017-12-31: 10000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 17.81 million
Calculation and evidence

-17800000 − 10000 USD

Exact free cash flow: -17810000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 33.69 million
Exact value

Exact value: -33693000 USD

2018-01-01 – 2018-12-31: -33693000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 22.8 million
Exact value

Exact value: -22800000 USD

2018-01-01 – 2018-12-31: -22800000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2,000
Exact value

Exact value: 2000 USD

2018-01-01 – 2018-12-31: 2000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 22.8 million
Calculation and evidence

-22800000 − 2000 USD

Exact free cash flow: -22802000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 107.5 million
Exact value

Exact value: -107500000 USD

2019-01-01 – 2019-12-31: -107500000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 37.5 million
Exact value

Exact value: -37500000 USD

2019-01-01 – 2019-12-31: -37500000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 136,000
Exact value

Exact value: 136000 USD

2019-01-01 – 2019-12-31: 136000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 37.64 million
Calculation and evidence

-37500000 − 136000 USD

Exact free cash flow: -37636000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 22.4 million
Exact value

Exact value: -22397000 USD

2020-01-01 – 2020-12-31: -22397000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 30.8 million
Exact value

Exact value: -30800000 USD

2020-01-01 – 2020-12-31: -30800000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 8,000
Exact value

Exact value: 8000 USD

2020-01-01 – 2020-12-31: 8000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 30.81 million
Calculation and evidence

-30800000 − 8000 USD

Exact free cash flow: -30808000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 336,000
Exact value

Exact value: -336000 USD

2021-01-01 – 2021-12-31: -336000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 68.9 million
Exact value

Exact value: -68900000 USD

2021-01-01 – 2021-12-31: -68900000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4,000
Exact value

Exact value: 4000 USD

2021-01-01 – 2021-12-31: 4000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 68.9 million
Calculation and evidence

-68900000 − 4000 USD

Exact free cash flow: -68904000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 61.23 million
Exact value

Exact value: -61226000 USD

2022-01-01 – 2022-12-31: -61226000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5.12 million
Exact value

Exact value: -5116000 USD

2022-01-01 – 2022-12-31: -5116000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4.66 million
Exact value

Exact value: 4660000 USD

2022-01-01 – 2022-12-31: 4660000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 9.78 million
Calculation and evidence

-5116000 − 4660000 USD

Exact free cash flow: -9776000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 86.88 million
Exact value

Exact value: -86879000 USD

2023-01-01 – 2023-12-31: -86879000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 81.18 million
Exact value

Exact value: -81177000 USD

2023-01-01 – 2023-12-31: -81177000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.13 million
Exact value

Exact value: 1132000 USD

2023-01-01 – 2023-12-31: 1132000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 82.31 million
Calculation and evidence

-81177000 − 1132000 USD

Exact free cash flow: -82309000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 60.48 million
Exact value

Exact value: -60477000 USD

2024-01-01 – 2024-12-31: -60477000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 59.92 million
Exact value

Exact value: -59917000 USD

2024-01-01 – 2024-12-31: -59917000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 123,000
Exact value

Exact value: 123000 USD

2024-01-01 – 2024-12-31: 123000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 60.04 million
Calculation and evidence

-59917000 − 123000 USD

Exact free cash flow: -60040000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

139 filings · 3,014 latest values · 3,005 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001485003, 1485003, CARM, EBIO, SESN, edgar:1485003

Also known as CARISMA THERAPEUTICS INC., Carisma Therapeutics Inc., Carisma Therapeutics Inc., Eleven Biotherapeutics, Inc., SESEN BIO, INC., SESEN BIO, INC., Sesen Bio, Inc.